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Abstract
Background: Tobacco smoke exposure (TSE) is a serious threat to child health. Roughly 40% of children
worldwide are exposed to tobacco smoke, and the very young are often “captive smokers” in homes in which
others smoke.
The goal of this research project is to develop and evaluate an intervention to reduce young child tobacco smoke
exposure. The objective of this paper is to document our approach to building the intervention, to describe the
planned intervention, and to explore the conceptual issues regarding the intervention and its evaluation.
Methods/Design: This project is being developed using an iterative approach. We are currently in the middle of
Stage 1. In this first stage, Intervention Development, we have already conducted a comprehensive search of the
professional literature and internet resources, consulted with experts in the field, and conducted several Design
Workshops. The planned intervention consists of parental group support therapy, a website to allow use of an
“online/offline” approach, involvement of pediatricians, use of a video simulation game ("Dr. Cruz”) to teach parents
about child TSE, and personalized biochemical feedback on exposure levels. As part of this stage we will draw on a
social marketing approach. We plan to use in-depth interviews and focus groups in order to identify barriers for
behavior change, and to test the acceptability of program components.
In Stage II, we plan to pilot the planned intervention with 5-10 groups of 10 parents each.
In Stage III, we plan to implement and evaluate the intervention using a cluster randomized controlled trial with an
estimated 540 participants.
Discussion: The major challenges in this research are twofold: building an effective intervention and measuring
the effects of the intervention. Creation of an effective intervention to protect children from TSE is a challenging
but sorely needed public health endeavor. We hope that our approach will contribute to building a stronger
evidence base for control of child exposure to tobacco smoke.
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An estimated 40% of children worldwide are exposed to
secondhand smoke (SHS) [1]. While exposure causes
serious damage to both children and adults, infants and
children are especially susceptible to SHS toxicity due to
their size and developmental stage [2]. SHS exposure
(SHSe) causes sudden infant death syndrome, reduced
birthweight, and ottitis media, asthma, pneumonia, and
impaired lung function in children [2]. Detrimental
health effects of exposure to SHS have been shown to
persist into adulthood, and children with parents that
smoke are known to be at a greater risk for tobacco use
themselves [3,4]. According to the World Health Orga-
nization, medical costs of children due to SHS have
been estimated at $703-$897 million in the US, $239.5
million in Canada, and $267 million in Britain [5].
Because of its potential impact, reduction of children’s
SHS exposure is on the agenda of major health organi-
zations, including the World Health Organization [1,6]
and US Healthy People 2020 [7].
Prior approaches to reducing SHS exposure among the
very young
Largely due to the difficulties of legislating bans in the
private domain [8], little legal action has been taken to
prevent the exposure of young children to SHS in the
home. The use of voluntary smoking bans in the homes
and cars of families with children is one possible
approach. Some evidence of public support for such am
approach exists in the US and elsewhere. In the summer
of 2001, for example, 74% of US households had indoor
smoking bans, with 84% reporting smoking bans in the
presence of children [9]; this is corroborated by another
study showing strict smoking bans in just over three
quarters of US households [10]. Support has been found
not only for voluntary smoking restrictions, but also for
those mandated by law. In Canada in 1996, nearly 40%
of residents supported legal restrictions on home SHS
child exposure [8]. The first ban on smoking with a
child in the car, enacted several years ago in Bangor,
Maine [11], was followed by bans in other places,
including Australia [12].
Some researchers have attempted to develop interven-
tion programs to reduce SHSe among children, particu-
larly in the home. These interventions have had limited
success in achieving their stated goals. In a 2006
Cochrane Collaboration review of 36 trials, only 11
showed statistically significant reductions in child expo-
sure to SHS. The review states: “Although several inter-
ventions, including parental education and counselling
programmes, have been used to try to reduce children’s
tobacco smoke exposure, their effectiveness has not
been clearly demonstrated.” [4]. The US Task Force on
Community Preventive Services [13], in its review of
community education to reduce exposure to SHS in the
home, found “insufficient evidence to determine effec-
tiveness ... because of the small number of available stu-
dies and limitations in their design and execution.”
Techniques such as intensive behavioral counseling
[5], motivational interviewing with children from low-
income households [14], and a brief intervention with
smoking mothers of newborns [15] have all shown some
success at reducing exposure to SHS or reducing paren-
tal smoking. The potential role of pediatricians has also
been highlighted [16], particularly because of their
responsibilities in some countries to report suspected
physical harm or neglect [17]. Some interventions in the
pediatric setting have shown benefit, particularly for
asthmatic children [18]. Other approaches have been
found to be feasible, such as the STOP program for
counseling parents in the hospital environment [19], or
acceptable, such as physician advice for protecting chil-
dren from SHS in the pediatric setting [20,21].
Challenges related to parental perceptions and practices
Several important challenges have been identified in the
literature on preventing children’se x p o s u r et oS H S ,i n
particular those associated with parental beliefs and prac-
tices regarding the impact of their own smoking on their
children, or the effectiveness of the prevention measures
which they employ. A central challenge is parents’ denial
of the detrimental effect of SHS caused by their own
smoking. For example, in one study, some smoking
mothers of young children, rather than admit their smok-
ing could potentially affect their children, preferred to
blame health-related issues on other factors, such as
genetics or environmental pollution [22]. Another chal-
lenge is that even when parents do recognize the potential
hazard of exposure to SHS, a large percentage (over 80%
in one study [23]) rely on simplistic “harm-reduction” stra-
tegies which they believe are effective, such as opening a
window. However, research shows such strategies to be
ineffective [24]. These two types of misconceptions pose
an important challenge in developing effective interven-
tions: in addition to providing the parents with resources
to adopt and maintain smoke-free environments for chil-
dren, parental misconceptions regarding harm reduction
must be addressed. For this purpose, a social marketing
approach, which draws on behavior-change theories
[25,26] will be used to augment findings from the compre-
hensive literature review, by systematically identifying par-
ents’ barriers to the adoption of recommended SHS-
reduction behaviors [27]. In addition, it will use a forma-
tive evaluation strategy [28] to enable the development of
appropriate theory-based means to address the challenges,
which will avoid stigmatizing parents or making them feel
guilty [29-31]. These behavior-change approaches include
social cognitive theory [32], risk communication, the
Rosen et al. BMC Public Health 2011, 11:508
http://www.biomedcentral.com/1471-2458/11/508
Page 2 of 11influence of social norms [33], and the use of various
media channels (which currently include the internet and
social network channels) to reach and attract the attention
of the intended parent population, and to provide perti-
nent and persuasive information on the issue. Further,
new media channels can play an important role in provid-
ing actual support and enhanced self-efficacy, which are
considered to be important factors in adopting health-pro-
moting behavior changes. Social marketing approaches
also emphasize the importance of identifying subgroups
(segments) within the intended population that may hold
particular beliefs, have particular needs, or can be sup-
ported through particular means. This segmentation can
be done on the basis of various factors, including particu-
lar “stage” of readiness to adopt the recommended beha-
vior [34]. Social marketing strategies have been
successfully applied in the area of tobacco use prevention
and cessation, and it has been recommended that they be
applied in the development of current smoking prevention
approaches [4,35,36].
Third hand smoke exposure
The concept of third-hand smoke (THS), defined as
“residual tobacco smoke contamination that remains
after the cigarette is extinguished,” has recently surfaced
as a closely related health issue. The term “tobacco
smoke exposure” (TSE), is used to include exposure to
both secondhand smoke and thirdhand smoke, and will
be used in the remainder of this protocol [10].
Primary hypothesis of the current study
The primary hypothesis of the current study is that a
parent-oriented theory-based intervention can reduce
tobacco smoke exposure (TSE) of young children, and
be evaluated in a valid manner.
Specific aims
The aims of the present research are to:
1. Develop a theory-based intervention based on a
social marketing approach to reduce TSE among
young children
2. Evaluate the effects of the intervention on TSE, as
measured by biochemical measures and parental
report
3. Evaluate the effects of the intervention on second-
ary endpoints: child health outcomes and parental
cessation
4. Explore the relationship between TSE and child
health
5. Explore the relationship between TSE as reported
by parents and as measured by biochemical means.
Methods/Design
Project Phases
The development and evaluation of the intervention,
detailed in Table 1, follows the model for the develop-
ment of lifestyle interventions presented previously by
Rosen et al. [37] The model specifies that the program
be developed in phases. In Phase I, the intervention is
constructed and tested with a small number of indivi-
duals, with an emphasis on acceptability and feasibility,
using a qualitative approach to evaluation. The interven-
tion is tested in Phase II in a real field setting, with a
limited number of individuals, often iteratively, using a
Table 1 Phased, evaluated development plan for intervention to reduce child exposure to tobacco smoke
Phase Activity
I. Program development
Systematic review of the professional literature (with meta-analysis)
Comprehensive search for intervention materials available online,
Consultation with experts
Creation of initial version of website
Development of research instruments (questionnaires and Interview Guides
Focus groups and in-depth interviews with parents about attitudes and practices regarding child tobacco smoke
exposure
Qualitative evaluation
Focus groups with parents on measurement of exposure
Qualitative evaluation
Design workshops to get feedback from parents on all elements of program.
Qualitative evaluation
II. Pilot Pilot all elements of intervention and research materials on 5-10 groups of 10 parents each.
Qualitative and quantitative evaluation
III. Cluster randomized
RCT
Randomize 18 clinics to early or late intervention, with 30 participants per clinic.
Quantitative evaluation of primary and secondary endpoints, qualitative and quantitative process evaluation.
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the intervention is tested, using a randomized design. In
Phase IV, large-scale implementation and penetration
are assessed in other populations. This project addresses
Phases I-III.
Phase I. Intervention Development
The following activities have been performed during
Phase I: (1) a broad literature review, which encom-
passed reports of previous intervention trials, informa-
tion provided by state and local governments for
parents and professionals interested in protecting chil-
dren from tobacco smoke exposure, and information
about parental attitudes towards smoking around chil-
dren; (2) consultations with leading international experts
in the field, (3) discussions with local health, communi-
cations, and parenting professionals, and (4) two early
design workshops on the topic of website development.
Based on the information and experience obtained
through these activities, we developed an initial inter-
v e n t i o np l a n .T h ep l a nw i l lb er e f i n e do nt h eb a s i so f
formative research, consisting of personal and group
interviews with parents and health professionals. The
aim of these interviews is to identify beliefs and knowl-
edge regarding smoking around children, perceived
social norms regarding parental smoking around chil-
dren, reliable information sources regarding smoking
hazards and smoking cessation, channels of influence
and support, and barriers obstacles to the adoption of
smoking bans in the home and car.
Focus groups (group interviews) and in-depth personal
interviews of parents will be conducted to elicit their
perceptions of risk and exposure, identify obstacles to
implementing smoke-free home and car policies, and
develop ideas for fully protecting their children from the
effects of TSE. The emphasis will be on the perspective
and needs of the target population, including what par-
ents understand about the damage caused by TSE, why
parents continue to smoke around their children despite
having some knowledge of the potential hazard of child
TSE, and what resources they need to overcome the
barriers that prevent them from adopting practices that
can help protect their children from TSE. Phase I will
also include preliminary testing of all program
components.
Phase II: Pilot of developed intervention
In Phase II, we plan to conduct a pilot study to fully
test all elements of the planned intervention program,
as well as all evaluation tools. Because the planned
intervention will be conducted with groups of parents,
and not with individuals, we adapt the formulation of
Phase II to accommodate work with groups. The origi-
nal formulation of Phase II called for recruiting partici-
pants and then offering them the developed
intervention. Instead, we plan to implement the
intervention in groups of 10 families each. We plan to
work with the first group of 10 parents, modify the
program according to initial results, and then run the
second group. This iterative approach to improving the
program will continue for 5-10 sessions, until we have
a feasible, well-accepted program with at least some
evidence of decrease in exposure levels. This continued
refinement of the program should allow us to fully and
immediately incorporate findings from early group ses-
sions, so that all modifications are tested prior to the
Phase III trial. The disadvantage of this approach is
that our estimate of intervention effect will be based
on fewer participants.
Phase III. Cluster randomized controlled trial
The study design for the Phase III trial is diagrammed
in Figure 1. In brief, it is a cluster randomized design,
with randomization at the level of the clinic, and
delayed project implementation in the control group.
Thus, the intervention group will receive the interven-
tion soon after entry to the study, while the control
group will receive the intervention at the close of the
study, some six months later. This design, which was
used previously in a trial of a preschool handwashing
intervention by several of the investigators in the cur-
rent research [38,39], enhanced the acceptability of the
trial to potential participants, and overcame ethical
objections to withholding possibly beneficial interven-
tion from control group members [40].
Population
The study will be conducted in Israel, where 20.9% of
the adult population smokes [41]. While there are no
nationally representative data on young child exposure
to SHS, one study conducted in Haifa showed that an
estimated 46% of infants less than one year old resided
in homes with one or more smokers [42]. Forty percent
of school-aged children in seventh through twelfth
grade are exposed to SHS in their homes [43].
All Israeli citizens are covered by the National Health
Insurance Law through one of four Health Maintenance
Organizations (HMOs). Participants for in-depth inter-
views, focus groups, and the Pilot Study will be recruited
through three clinics owned by Meuhedet, an HMO
which serves a million individuals. The clinics are
located in three different cities in Israel, all of which are
located in the center of the country. Each of these
clinics will give us a unique perspective on trying to
control secondhand smoke exposure in different
populations.
City X has a middle-income heterogeneous popula-
tion, City Y has a primarily Ultra-Orthodox population,
and City Z has a mixed-income heterogeneous popula-
tion which includes a high percentage of immigrants
from the former Soviet Union. Men from the former
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Jewish Israelis [44]. The Ultra-Orthodox males have
rates of smoking which are similar to other Jewish
males, while the Ultra-Orthodox females have very low
smoking rates. Consequently, in the City Y clinic, the
emphasis will be on controlling exposure of children in
a population where many fathers smoke but few
mothers do, while in the other areas, the focus will be
on households where either parent smokes or both par-
ents smoke.
Potential participants coming for a visit to their Meu-
hedet clinic will be find posters and flyers advertising
for participants in the project. In addition, they will be
approached by the clinic staff (physicians, nurses, health
promoters, or secretaries) and asked to agree to be con-
tacted by project personnel for possible participation in
the study. The eligibility criteria are as follows:
1. The child is a Meuhedet member, cared for in one
of the participating clinics.
2. At least one parent is a current smoker.
3. The child is of the appropriate age (< 3 years of
age).
4. The child has sufficient hair growth for hair
samples.
5. The parents give consent for participation in the
research.
We will attempt to contact all candidates, inform
them about the study, and invite them to join. Partici-
pating parents will sign Informed Consent Forms.
Intervention
General Focus
Previous work has focused on one of two primary goals:
convincing parents to quit smoking or convincing them
to reduce the exposure of their children [6]. Parental
cessation is the ideal, but poses several significant pro-
blems regarding reducing child TSE: (1) Many parents
are not interested in quitting. (2) Among parents who
try to quit, many fail entirely and others relapse. (3)
Even if one parent quits, another parent or household
resident may continue to smoke, still leaving the child
exposed, and (4) even if both parents quit, the child
may still be exposed by others inside or outside the
home.
These factors suggest that a focus on reducing expo-
sure has important advantages. It would allow recruit-
ment of a broader segment of parents, because parents
who are not willing to consider quitting might also be
interested in joining. In addition, the program would
address elimination of all exposure to SHS, from any
source. Further, it may help parents consider cessation,
when they see they can be provided with a supportive
environment that offers them the means to reduce their
smoking or quit all together.
Drawing on these considerations, we have chosen a
combined approach. Our main focus will be on reducing
child TSE, but we will also include elements that will
provide support for parental smoking cessation. Specifi-
cally, cessation will be encouraged and facilitated
Enroll women from 18 clinics 
(30 children per clinic, N=540)
Randomize clinics to intervention or control
Intervention (N=9 clinics, N=270 children) 
Measurement 1: Baseline
Control (N=9 clinics, N=270 children) 
Measurement 1: Baseline
Implement Program No Program
Measurement 2
Evaluate effectiveness of program
Close of formal trial period
Implement Program
Measurement 2
Evaluate effectiveness of program
Close of formal trial period
No program
Figure 1 Flowchart of Study Design.
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the healthcare system. It should be noted that group
therapy for smoking cessation, along with cessation
medications for those participating in group therapy, are
heavily subsidized for all Israeli citizens.
Intervention Components
The main components of the planned intervention are
as follows:
1. Group support sessions to help parents create and
maintain smoke-free homes, and protect their children
from exposure, run by experts in parenting skills
2. A project website which will be used in conjunction
with the group support sessions. The parents will have
access to information provided by the Project and will
be able to engage in online discussions with project per-
sonnel and each other. This will create an “online/off-
line” approach to working with the parents.
3. Providing results of biochemical measures of child
exposure as a means to illustrate to parents the extent
of their child’s TSE.
4. A video simulation game ("Dr. Cruz”) developed to
inform parents about exposure levels and risks of expo-
sure while smoking in a car with a child present [45].
5. Informing participants’ physicians about the project
and providing them with information about the dangers
of TSE to child health, including CEASE (Clinical Effort
about Secondhand Smoke Exposure) materials [46].
The main intervention tool will be the group support
sessions. To date, while some studies have assessed indi-
vidual counseling for reduction of child exposure [4],
none has assessed group counseling for this purpose.
Thus, our consideration of group counseling represents
a novel contribution. Studies in the area of smoking ces-
sation have shown that group support, a relative newco-
mer to the field of tobacco control, is an effective
intervention [47]. These results support the use of
group therapy in the context of reducing child TSE. We
will focus on the importance of protecting young chil-
dren from TSE, and on ways to implement and maintain
smoke-free environments for the child. We will seek to
“denormalize” smoking around children, and to promote
the goal of keeping homes and cars completely smoke-
free. The sessions will be run by counselors experienced
in working with parents of young children.
Using new communication technologies (internet for-
ums, chat rooms, mobile phone text messages, etc.) is a
relatively recent but promising concept in health pro-
motion [48]. A review of internet-based smoking cessa-
tion programs showed that some internet-based
interventions can aid smoking cessation [49]. In our
program, we plan to augment the group support with a
website which will provide a forum for discussion
among parents, as well as a means for project personnel
to communicate with parents. The idea is to use an
“online/offline” approach to create a community of par-
ents who are trying together to protect their children.
Personalized feedback in the form of biochemical test
results has been previously used to decrease TSE. The
Emmons study [50], one of the few studies with proven
benefit, included biofeedback on the amount of nicotine
present in homes. We plan to provide parents with
results of biochemical measures of their child’s level of
TSE (specifically, hair nicotine levels) to help them
internalize their children’s true exposure levels.
T h ea b o v ec o m p o n e n t sw i l lb es u p p l e m e n t e dw i t ha
video simulation game (called “Dr. Cruz”)a n di n f o r m a -
tional materials provided to the participants’ physicians
(including CEASE materials). This particular simulation
proved feasible to deploy in medical waiting rooms for
low-income populations in the US (California Central
Valley and Kentucky), and it showed initial positive
impact in terms of increased awareness of SHS in cars
and intentions to change behavior [45].
P a r e n t sw i l lb ee n c o u r a g e dt oq u i ts m o k i n g ,b u t ,a t
the same time, they will be informed that they do not
have to quit to participate in the program. Parents inter-
ested in quitting will be provided with information on
existing cessation services within their HMO. In addi-
tion, we may provide nicotine replacement therapy for
use in promoting smoke-free homes and cars. This
approach has been taken by previous researchers, with
promising results [51].
Outcome Measures
List of Outcome Measures
The primary outcome measure of the Phase III trial will
be child TSE as assessed by hair nicotine.
Secondary outcome measures are:
1. Child TSE, as assessed by parental report
2. Adoption of voluntary smoking bans in homes and
cars
3. Risk perception, attitudes and knowledge regarding
child TSE
4. All child respiratory symptoms, including sneezing,
wheezing, coughing, sore throat, and ear infections, as
reported by the parents.
5. Parental smoking cessation, number of parental quit
attempts, use of cessation medications, attendance at
behavioral cessation sessions
Measurement
Measurement of TSE ￿ Hair nicotine levels. Hair will be
cut at the scalp prior to and 3-6 months after the
intervention. Several centimeters of several hairs will
be taken from hair at the scalp. The proximal 1 cm
of hair represents exposure during the previous
month.
￿ Parental report of child TSE, obtained through
questionnaires, including information on frequency
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smoking bans in house and car, smoking behavior of
frequent and occasional visitors; exposure to regular
smoking elsewhere (such as in daycare or at
grandparent).
Justification of choice of TSE measures The measure-
ment problem is a difficult one, and deficiencies in mea-
surement, whether due to poor sensitivity or bias, may
be a contributor to the mediocre results often observed
in previous programs. If the measures used are not sen-
sitive enough to detect small differences, then the
“noise” in the measurements will obscure being able to
document true effects of an intervention. If the mea-
sures are biased, and that bias is affected by intervention
group (for example, with parental report), then spurious
effects may be observed.
There are two approaches to measurement of child
TSE: parental report and biochemical measurement.
Neither method is perfect: parental report may be com-
promised by lack of knowledge of child exposure, lack
of awareness of that exposure, or social desirability bias.
The most widely accepted measure of parentally-
reported exposure is number of cigarettes to which the
child is exposed. In our early piloting of questionnaires,
this measure proved difficult for parents to answer.
Several past studies found parental report to be suffi-
cient [52-54], while other studies showed parents under-
reported exposure [55] or that such reports were
unreliable [56]. In 2006, the US Surgeon General recom-
mended use of biomarkers, particularly cotinine for
assessment of SHS exposure [2]. The recent Cochrane
2006 review of programs to reduce children’se x p o s u r e
to SHS [4] stated “We take biological verification of
exposure to or absorption of ETS [Environmental
Tobacco Smoke] as the “gold standard”, and recom-
mended the use of hair nicotine for estimation of long-
term exposure.
One review examined reported correlations between
biochemical measures and parental report from a num-
ber of studies, and found that correlations between par-
ental report and nicotine ranged from .22 - .75, while
correlations between parental report and cotinine ran-
ged from .28 - .71 [52] While this may be sufficiently
accurate to differentiate between children of smokers
and non smokers, it may not be accurate enough to
detect differences in levels of exposure obtainable by
intervention programs.
Our decision to use hair samples was based primarily
on the higher precision of hair nicotine found in the lit-
erature [57]. Logistical considerations were also impor-
tant, as the samples need to be shipped internationally
for analysis, and transport delays of biologically perish-
able samples could result in loss of data. Indeed, a
report of a very recent study includes measurement of
exposure using hair nicotine [51], perhaps for similar
reasons to ours.
Statistical Considerations
Statistical analysis
The Phase I and II results will be analyzed primarily
through descriptive methods. In the Phase III trial, the
effectiveness of the intervention on hair nicotine level
and parental report of child TSE will be analyzed using
linear mixed models, which will take into account
dependencies in the dataset due to within-clinic correla-
tions between parents. Clinic will be included as a ran-
dom effect. Baseline hair nicotine level will be included
as a covariate. Potential confounding variables relating
to socioeconomic status, ethnicity, and religiosity, as
ascertained from the initial parental interview, will be
included as covariates.
Sample size calculation for the Phase III trial
The final sample size calculations for the Phase III trial
will be based on results from the Phase II pilot study.
Preliminary calculations have been made on the basis of
published data for hair cotinine, and hair nicotine
[58,59]. These calculations are based on a power of 0.8
and a 2-sided alpha-level of 0.05. The published data we
have used are population or sample level data on levels of
hair cotinine in children exposed or not exposed to SHS,
or on levels of hair nicotine in children whose parents
smoke in the house, smoke only outside the house, or do
not smoke at all. We made the following assumptions:
a. The aspirational goal is elimination of TSE among
the children. However, our more realistic, operative
goal, on which sample size calculations were per-
formed, is a reduction i ne x p o s u r e .W ed e f i n ea
detectable change of substantive importance as one
w h i c hp r o d u c e sac h a n g ei ne x p o s u r ee q u i v a l e n tt o
one third the difference in measured hair values
between children exposed and unexposed to tobacco
smoke.
b. There will be some leakage of the intervention to
the control group, as a direct result of the recruit-
ment process. This is consistent with the improve-
ments seen in twelve out of eighteen trials in the
control groups, of studies included for review in the
Cochrane systematic review [4]. We assume that this
contamination will occur in 10% of the recruited
children in the control group. This number is based
on observed changes in a previous health interven-
tion trial which was run by two of the authors of the
present study [39]. Thus, the expected outcome in
the control group is a weighted average of the values
for exposed children (90%) and the expected change
as a result of the intervention (10%).
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sample sizes due to the possibility that some of the
variance is due to similarities within children attend-
ing the same clinic. The inflation factor we used is
1.145.
d. We further assume that 20% of the children
recruited will be lost to follow-up.
Based on our tentative calculations, a total of eighteen
clinics will be randomized equally to intervention and
control groups. Thirty children will be recruited from
each clinic. Five hundred and forty infants will be
recruited to the study.
We assume that treatment is allocated at the clinic
level, with the same number of clinics in each of the
two arms. The sample size calculations are based on (1)
published descriptive statistics for hair nicotine and hair
cotinine, (2) specified effect sizes, (3) a projected average
clinic size of 30 infants, and (4) a projected response
rate of 80%. The sample sizes are also adjusted using an
inflation factor to account for the correlation between
children attending the same clinic.
Sample size formula The total sample size is calculated
by the following standard formula: [60]
Total N = 4σ2 ∗ (za +z b)
2/ 2
Here za =1 . 9 6a n dz b = 1.28, for 90% power at the
two-sided 0.05 level, Δ is the relevant effect size, and s
is the relevant standard deviation (SD). The sample size
is then multiplied by the Inflation Factor (IF) and
divided by the expected response rate of 0.8.
Specification of the effect size The effect of SHS can be
expressed as the ratio of the hair nicotine or cotinine
level between exposed and unexposed populations. We
assume that the program will reduce this ratio by 25%,
33%, or 50%. We further assume that, due to leakage of
the program to the control group, the ratio will be
reduced in the control group by an amount equal to
10% of the reduction in the treated group (i.e. 2.5%,
3.3%, or 5%).
We perform the calculations on a logarithmic scale.
Denote by R the reduction achieved by the program.
The effect size (i.e. difference between treatment groups)
on the logarithmic scale is then given by
  =l o g(1 - 0.10 ∗ R) − log(1 − R).
For R = 0.25, 0.33, and 0.50, the corresponding Δ
values are Δ = 0.26, 0.37, and 0.64.
Estimation of the Inflation Factor (IF) The IF is deter-
mined by the intraclass correlation coefficient (ICC) and
the number of children per clinic [61]. The formula is
IF = (1+(m-1)r), where m is the average number of chil-
dren per clinic and r is the ICC. As was done by the
authors of a previous study, we assume r = 0.005. Our
assumed clinic size is m = 30. Hence the IF is given by
IF = 1+29*0.005 = 1.145.
Estimation of the standard deviation (SD)
Hair Nicotine
Our endpoint is log hair nicotine level. Al-Deleimy et al.
[59] presented geometric means and associated confi-
dence intervals for hair nicotine. These results were gen-
erated by computing arithmetic means and associated
confidence intervals for log hair nicotine and then back-
transforming to the original hair nicotine scale. From
the results presented in the Al-Deleimy paper, we can
derive the SD for log hair nicotine in the Al-Deleimy
study.
Al-Deleimy et al. presented data for nonsmoking
families, parents who smoked only outside the house,
and parents who smoked inside the house as well as
outside. Table 2 presents the published results and the
corresponding SD’s for log hair nicotine. Given the
a b o v er e s u l t s ,w ee s t i m a t et h eS Df o rl o gh a i rn i c o t i n e
at s = 1.00.
Hair Cotinine
Florescu et al. [58] presented descriptive statistics for
hair cotinine for various populations. We focus on the
population of children, either exposed or unexposed to
tobacco smoke.
Florescu et al. state on page 440 of their paper that
hair cotinine did not follow a normal distribution, and
they therefore presented geometric means and some
other statistics of interest. We take log hair cotinine as
our endpoint, and assume that it is normally distributed.
From standard mathematical results for the lognormal
distribution, we can use the results in the Florescu et al
paper to calculate estimates of the mean and SD of log
hair cotinine.
The estimated means for log hair cotinine are in close
agreement with the reported geometric means for hair
cotinine previously reported [exp(-1.59) = 0.20 vs. 0.19,
exp(-0.84) = 0.42 vs. 0.48]. Based on the results, we esti-
mate the SD for log hair cotinine at s = 1.15.
Table 2 Hair Nicotine Results From Al-Deleimy et al
Published N Published Geometric Mean Published Confidence Interval SD for Log Hair Nicotine
No exposure 101 0.58 [0.49,0.68] 0.84
Smoke outside the house 69 2.63 [2.03,3.40] 1.09
Smoke inside the house 127 5.62 [4.60,6.86] 1.15
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ment, the calculated total sample sizes for log hair nico-
tine and log hair cotinine at the various levels of R are
as follows (rounded up to the nearest 10) as seen in
Table 3.
The calculated sample sizes are higher for log hair
cotinine than for log hair nicotine. This is consistent
with the claims that hair nicotine is more sensitive than
hair cotinine.
Using R = 0.33 and taking log hair nicotine as the
endpoint, we get a total sample size of 450 infants.
Since the number of infants has to be an even multiple
of the clinic size, which we are assuming is 30, we get a
total sample size of 480. We increase this to 540 infants
as a security measure against possible clinic dropout
and the uncertainty in the estimates used. We thus set
the tentative total sample size at 540 infants (9 clinics in
each of the two arms, with 30 infants per clinic). The
final choice of endpoint and sample size will be made
on the basis of locally-collected data.
Ethical approval and trial registration
Institutional Review Board approval has been obtained
from the Ethics Committee of the Sackler Medical
Faculty at Tel Aviv University. All participants will pro-
vide written informed consent. The trial is registered
with the NIH trials registry database (ClinicalTrials.gov
Identifier: NCT01335178).
Discussion
This paper describes the planning process, a proposed
program and its theoretical rationale, and an evaluation
design of an innovative intervention to protect young
children from tobacco smoke exposure. The primary
challenges of this work are to (1) develop an effective
theory-based intervention, and (2) to measure the effects
with sufficient accuracy and precision to detect a true
interventional effect.
Existing reviews of published reports show, overall,
that the effects of similar interventions were either small
or nonexistent [13,62-65]. This is consistent with many
findings of health promoting community based interven-
tions [66]. Findings could be due to one or a combina-
tion of three reasons: either the intervention programs
tested were ineffective, the programs were effective but
were not sufficiently well implemented, or the
measurement of the results was not sufficiently accurate
to detect the effects of the intervention.
Our developed program builds on recent ideas of
others from the fields of parenting, health communica-
tion (new media and online/offline approach), smoking
cessation (group therapy), and reduction of exposure
(CEASE materials for involvement of physicians, bio-
chemical feedback for internalization about personal
exposure levels, Dr. Cruz for education about TSE in
cars with smokers, and possible use of NRT for main-
taining smoke-free homes and cars). We avoid the com-
mon failure of using “one shot” or very short-term
interventions, by using multiple group meetings aug-
mented by a website. Our developmental plan ensures
that the full trial will not go forward until we have evi-
dence of feasibility and some indication that it is effec-
tive (albeit in an uncontrolled manner).
Conclusions
In this article we present our rationale for and method
of program development, proposed intervention plan,
and evaluation plan. We describe a design that draws on
social marketing and behavior-change approaches that is
parent-focused and allows parents to join the program,
even if they initially do not intend to quit smoking, and
offers them a group support system that will address
their concerns and needs. We identify important chal-
lenges faced by researchers interested in developing and
evaluating interventions to reduce child exposure to
tobacco smoke face, and offer specific strategies to
address them. The proposed approach and its rationale
can serve to contribute to building the science base for
the development and testing of intervention approaches
for health-promoting practices, and in particular the
protection of children from tobacco smoke exposure.
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